A
44
-7
EIX
56
-3
PPL
59
2
EQR
47
2
DVA
47
-4
SYK
31
-4
MMC
57
3
ADP
53
-2
TRIP
50
-2
DE
43
-2
MCD
42
-4
SWK
59
-2
ECL
59
-3
FLS
61
-2
CCL
89
-3
URBN
54
-4
MU
76
-3
BWA
53
-2
CPB
35
-4
BMY
76
-2
A
44
-7
EIX
56
-3
PPL
59
2
EQR
47
2
DVA
47
-4
SYK
31
-4
MMC
57
3
ADP
53
-2
TRIP
50
-2
DE
43
-2
MCD
42
-4
SWK
59
-2
ECL
59
-3
FLS
61
-2
CCL
89
-3
URBN
54
-4
MU
76
-3
BWA
53
-2
CPB
35
-4
BMY
76
-2
Financhill
Back

Tate & Lyle Plc Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Buy
51

TATYF
Tate & Lyle Plc

Last Price:
$5.19
Seasonality Move:
-4.04%
Buy
63

GPCR
Structure Therapeutics, Inc.

Last Price:
$68.89
Seasonality Move:
-34.19%
Buy
51
Tate & Lyle Plc (TATYF) is a Buy

Is Tate & Lyle Plc a Buy, Sell or Hold?

  • The current Tate & Lyle Plc [TATYF] share price is $5.19. The Score for TATYF is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
  • TATYF is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
63
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

TATYF Stock Price Chart

What is Tate & Lyle Plc's stock price today?

  • The Tate & Lyle Plc share price today is $5.19
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TATYF is experiencing slight buying pressure.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $71.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

TATYF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.27 Buy
Relative Strength Index (14 RSI): 66.5 Buy
Chaikin Money Flow: 0 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (4.91 - 5.07) Buy
Bollinger Bands (100): (4.86 - 6.84) Sell

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.5 Buy
Relative Strength Index (14 RSI): 72.85 Buy
Chaikin Money Flow: 1903413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.41 - 65.27) Buy
Bollinger Bands (100): (17 - 45.24) Buy

TATYF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.06 Buy
20-day SMA: 4.99 Buy
50-day SMA: 5.03 Buy
200-day SMA: 6.56 Sell
8-day EMA: 3.68 Buy
20-day EMA: 2.02 Buy
50-day EMA: 0.93 Buy
200-day EMA: 0.25 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.43 Buy
20-day SMA: 52.92 Buy
50-day SMA: 40.28 Buy
200-day SMA: 26.09 Buy
8-day EMA: 64 Buy
20-day EMA: 55.88 Buy
50-day EMA: 44.22 Buy
200-day EMA: 31.26 Buy

Tate & Lyle Plc Earnings Growth & TATYF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

Tate & Lyle Plc Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):